ACTSI Investigator Dr. Lawrence Phillips in the News

Lawrence Phillips, MD, ACTSI investigator, professor, Endocrinology Division, Emory University School of Medicine, and serves as medical director for the Clinical Studies Center at the Atlanta VA Medical Center. Diabetes is a public health problem of epidemic proportions in the U.S. and around the world. Dr. Phillips’ research is aimed to improve the early diagnosis and management of diabetes and pre-diabetes – to sustain beta cell function and improve the natural history of the disease. In his free time, Dr. Phillips has sung choral music for over 50 years, and met his wife (of 42 years!) through performing Beethoven’s Ninth Symphony with the Atlanta Symphony Orchestra and Chorus. 

Emory News Center| Diabetes researchers urge screening and management to benefit millions 

September 23, 2014


American Medical News | Programs deliver success for overweight, diabetic patients

July 8, 2013

Emory News Center | VA obesity study shows lifestyle change can work in a large health care system
June 25, 2013


Atlanta Business Chronicle | Diabetes trial

June 14, 2013

Atlanta Business Chronicle | Emory-VA collaborate on diabetes drug study

June 6, 2013

Atlanta Journal-Constitution | Anti-aging medicine earns converts and critics

September 24, 2012

Health News Digest | Type 2 Diabetes: Normal glucose levels should be the goal

August 1, 2012

Phillips is the principal investigator of a R21 grant from NIH entitled, Reach, Outcomes, and System Impacts of the VA’s National Weight Loss Program, MOVE. Phillips – Emory and the Atlanta VA Medical Center are participating in a new NIH study comparing the long-term benefits and risks of four widely used type 2 diabetes drugs in combination with the first-line drug metformin.


Depression, deficits in functional capacity, and impaired glycemic control in urban African Americans with type 2 diabetes. J Psychiatr Res 2014 May;52:21-7. 

Aging is associated with increased HbA1c levels, independently of glucose levels and insulin resistance, and also with decreased diagnostic specificity. Diabet Med 2014 Apr 2. doi: 10.1111/dme.12459. [Epub ahead of print] 

Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study. Menopause 2014 Mar;21(3):260-6.<

Predictors of Diabetes Mellitus and Abnormal Blood Glucose in Patients Receiving Opiod Maintenance Treatment. American Journal on Addictions 2013: 22(4); 411-416. Sex Hormone Levels and Risk of Breast Cancer With Estrogen Plus Progestin. J Natl Cancer Inst 2013; 105(19)1496-1503.

Screening for diabetes and prediabetes should be cost-saving in patients at high risk. Diabetes Care 2013: 36(7); 1981-1987. 

Science Advance: Emory-VA Collaborate on Diabetes Drug Study